semaglutide step STEP-HFpEF Trial Obesity care ≠ number on

If you're planning pregnancy, FDA guidance recommends discontinuing semaglutide approximately 2 months before a planned pregnancy and tirzepatide about 1 month before conception due to potential fetal risks

Publicacin revisada por: Referencias bibliogrficas Smits MM, Van Raalte DH

Orally administered semaglutide versus GLP-1 RAs in patients with type 2 diabetes previously receiving 1-2 oral antidiabetics: systematic review and network meta-analysis

Discontinue if pancreatitis is suspected

The key concern is not whether you can take these medications togethermany patients dobut rather that your healthcare provider must track specific lab values regularly

Unadjusted values of changes in secondary outcomes are reported in Supplementary Table 4